MustGrow Biologics Corp.
MGRO.V
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.98M | 2.92M | 289.60K | 3.67M | 3.46M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.98M | 2.92M | 289.60K | 3.67M | 3.46M |
| Cost of Revenue | 4.25M | 2.53M | 229.90K | 187.60K | 178.00K |
| Gross Profit | 736.90K | 392.80K | 59.70K | 3.48M | 3.29M |
| SG&A Expenses | 3.80M | 3.40M | 2.79M | 2.82M | 2.71M |
| Depreciation & Amortization | 17.10K | 7.50K | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.45M | 6.37M | 3.58M | 3.53M | 3.41M |
| Operating Income | -3.47M | -3.44M | -3.29M | 133.80K | 49.90K |
| Income Before Tax | -4.03M | -3.94M | -3.57M | -179.80K | -334.00K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.03 | -3.94 | -3.57 | -0.18 | -0.33 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.03M | -3.94M | -3.57M | -179.80K | -334.00K |
| EBIT | -3.47M | -3.44M | -3.29M | 133.80K | 49.90K |
| EBITDA | -1.49M | -865.90K | -- | -- | -- |
| EPS Basic | -0.08 | -0.08 | -0.07 | 0.00 | -0.01 |
| Normalized Basic EPS | -0.05 | -0.05 | -0.04 | 0.00 | 0.00 |
| EPS Diluted | -0.08 | -0.08 | -0.07 | 0.00 | -0.01 |
| Normalized Diluted EPS | -0.05 | -0.05 | -0.04 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 210.09M | 209.60M | 206.65M | 205.33M | 203.57M |
| Average Diluted Shares Outstanding | 210.09M | 209.60M | 206.65M | 205.33M | 203.57M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |